A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumours
Gerhardt Attard(London Cancer), Maja J.A. de Jonge(Erasmus MC), Jianguo Zhi(Roche (Switzerland)), Peter C.C. Fong(Royal Marsden NHS Foundation Trust), Sarah P. Blagden(Churchill Hospital), Johann S. de Bono(Royal Marsden NHS Foundation Trust), Jos Kitzen(Erasmus MC), Jaap Verweij(Deutz (Germany)), L. Pronk(Roche (Switzerland)), Gerhard Zugmaier(Amgen (Germany))
Cited by 71
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Cremophor EL
|European Journal of Cancer|2001|1.6k